
Background Early and accurate diagnosis is critical for intervening in the progression of Alzheimer's disease (AD). However, traditional clinical diagnostic techniques, such as invasive cerebrospinal fluid punctures and expensive neuroimaging, struggle to meet the demands of large-scale early screening.Methods This study proposes a novel transcriptomic-based diagnostic framework named DeepFS, which features an automated gene selection module to filter out redundant noise and identify high-value core gene targets for diagnosis.Results DeepFS achieved high-precision identification of AD, yielding an ac-curacy of 89.45% and an AUC value of 0.9647 on brain tissue transcriptomic data. To further explore the methodological generalizability of the framework across different tissue types, we extended DeepFS to a peripheral blood transcriptomic dataset, where it consistently achieved reliable diagnostic classification performance. Furthermore, regarding the brain tissue transcriptomic data, the high-weight genes driven by the gene selection module were integrated with AD brain single-nucleus RNA sequencing data for quantitative analysis at single-cell resolution, further validating the biological efficacy of the module.Conclusion DeepFS not only exhibits competitive performance in AD diagnostic classification, but can also serve as a valuable prior reference for future AD biomarker research.
Deep-sea hydrothermal sediments are enriched in transition metals that exert selective pressure on resident microbial communities. Despite the recognized influence of metal toxicity on microbial diversity, the genomic basis of metal resistance and its phylogenetic distribution in hydrothermal deposits and the surrounding sediments of the Southern Mid-Atlantic Ridge (SMAR) remain poorly understood. Here, we performed metagenomic sequencing of surface sediments collected from five SMAR stations and reconstructed 157 high- and medium-quality non-redundant metagenome-assembled genomes (MAGs) to investigate the taxonomic diversity and genome-resolved distribution of metal resistance genes (MRGs). The recovered MAGs represented 15 bacterial and archaeal phyla, with Pseudomonadota dominating the community, followed by Nitrospirota and Bacteroidota. Annotation of the recovered MAGs revealed widespread resistance potential to multiple metals, indicating that diverse metal resistance mechanisms are broadly conserved across SMAR sediments. Genome-resolved taxonomic analysis further demonstrated pronounced lineage-specific patterns of MRG distribution. Gammaproteobacteria encoded the most diverse repertoire of resistance determinants, whereas Alphaproteobacteria preferentially harbored arsenic- and mercury-resistance genes. Other taxonomic groups exhibited specialized adaptive strategies, including zinc homeostasis in Bacteroidota. Our genome-resolved analyses demonstrate that metal resistance potential in SMAR sediments is taxonomically structured distribution, reflecting differences in genomic potential among microbial lineages to hydrothermal metal enrichment. These findings expand our understanding of microbial survival strategies in deep-sea hydrothermal ecosystems and provide a genomic framework for future studies of metal cycling in the deep ocean.
Arachidonate 5-lipoxygenase (5-LO) and its activating protein, encoded by ALOX5 and ALOX5AP respectively, are two leukotriene pathway proteins suspected to play a role in atherosclerotic cardiovascular disease (ASCVD) through inflammatory mechanisms. Prior genetic association studies linking ALOX5 and ALOX5AP to ASCVD have motivated clinical trials of 5-LO inhibitors, such as atreleuton, which was associated with reduced atherosclerotic plaque progression in patients with a recent acute coronary syndrome in a phase II trial. However, the effect of 5-LO inhibition on ASCVD clinical outcomes remains unclear. Using data from the UK Biobank, we revisit previously reported genetic associations of ALOX5 and ALOX5AP with ASCVD using a multi-ancestry meta-analysis including data from 378,962 participants. We characterize ancestral differences in previously studied ALOX5 and ALOX5AP polymorphisms which could have led to population stratification. When adequately accounting for ancestry, these previous associations were not replicated. In addition to our replication efforts, we used association scans and transcriptome-wide association studies to test the involvement of leukotriene pathway genes with ASCVD. Overall, our results do not support a role for genetic variation in ALOX5 or its activating protein in ASCVD risk.
GERBase is a web tool that provides family-phased, high-resolution Human Leukocyte Antigen (HLA) allele and haplotype frequencies together with linkage disequilibrium (LD) metrics. The tool supports haplotype blocks defined by the user's query, as well as stratification by self-reported race or visualization of the total admixed population. For analysis, HLA alleles were grouped by antigen recognition domain (ARD), while the web tool retained the ability to discriminate between alleles within the same group. The database contains 17,260 haplotypes from unrelated candidates for hematopoietic cell or kidney transplantation, typed at IGEN (S & atilde;o Paulo, Brazil), phased by segregation analysis in family studies rather than statistically inferred; 9,026 haplotypes (52.3%) are phased across all nine classical loci, and the remainder across at least two. Allele frequencies in GERBase closely track those reported for the Brazilian donor registry in the Common, Intermediate, and Well-Documented (CIWD)-Brazil catalog (r = 0.9988; P < 0.0001 across 238 alleles). This tool can be used in the daily practice of HLA laboratories, including the investigation of allele dropout, the optimization of virtual crossmatching when donor HLA typing is incomplete, and the enhancement of donor prioritization for allogeneic hematopoietic cell transplantation. GERBase is available at https://www.igen.org.br/gerbase/, does not require registration and is free to use.
BackgroundDown syndrome (DS, trisomy 21) is the most prevalent human autosomal aneuploidy, driven by non-disjunction of chromosome 21 during maternal gametogenesis. Centromere-kinetochore complexes mediate accurate chromosome segregation, and centromeric protein dysregulation is linked to chromosome instability; nevertheless, how perturbations of centromere-proximal proteins drive cellular pathogenesis in DS remain poorly defined.MethodsWe applied CENPA-GFP-APEX2 proximity labeling coupled with LC-MS/MS quantitative proteomics to systematically profile CENPA-proximal proteins in euploid normal amniocytes (NACs) and trisomy 21 DS-derived amniocytes (DSACs). Differentially abundant candidate proteins (DAPs) were biochemically validated by Western blot, followed by bioinformatic enrichment analyses. The top upregulated candidate Interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) was overexpressed in human induced pluripotent stem cells (hiPSCs) to dissect its functional impacts on DS-relevant cellular phenotypes. RNA-seq transcriptome profiling was conducted to uncover signaling and metabolic pathways perturbed by IFIT3 overexpression, and mitochondrial functional assays were performed to validate bioinformatic predictions.ResultsWe quantified 999 total CENPA-proximal proteins via label-free proteomics, identifying 32 DAPs in DSACs relative to NACs (19 upregulated, 13 downregulated). Enrichment analyses revealed robust dysregulation of interferon response and ribosomal protein networks in DSACs, with IFIT3 exhibiting the most significant upregulation. Lentiviral IFIT3-OE in pluripotent hiPSCs triggered G1-phase cell cycle arrest, suppressed cell proliferation, and elevated apoptotic rates. Transcriptome-wide RNA-seq demonstrated strong transcriptional repression of oxidative phosphorylation and mitochondrial ATP biogenesis gene sets, accompanied by direct functional deficits including reduced mitochondrial membrane potential and lowered intracellular ATP levels.ConclusionThis study identifies IFIT3 as a highly dysregulated CENPA-proximal candidate protein in fetal DS amniocytes. Gain-of-function assays in hiPSCs confirm that elevated IFIT3 expression is sufficient to disrupt mitochondrial homeostasis and recapitulate core DS cellular defects. Our work provides a novel proteomic framework linking centromere-proximal signaling to mitochondrial dysfunction in trisomy 21, and highlights IFIT3 as a candidate mediator of DS pathogenesis.